[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351464-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351464-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","single-cell-triomics-analysis-of-tumor-cells-infiltrating-patient-derived-breast-cancer-scaffolds","Single-Cell Triomics Analysis of Tumor Cells Infiltrating Patient-Derived Breast Cancer Scaffolds","","Single-cell triomics is introduced to assess DNA, RNA, and protein from the same tumor cell using a targeted sequencing strategy. Breast cancer cells grown as monolayers and within patient-derived scaffolds that mimic in vivo conditions—under chemotherapy and non-chemotherapy settings—are profiled. DNA, RNA, and protein biomarkers are measured reliably, revealing tumor cell heterogeneity. Chemotherapy shifts subpopulations and biomarker expression, while scaffold-derived microenvironments from different cancers modulate heterogeneity and drug resistance, supporting triomics for multi-layer characterization of cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/single-cell-triomics-analysis-of-tumor-cells-infiltrating-patient-derived-breast-cancer-scaffolds/351464/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/single-cell-triomics-analysis-of-tumor-cells-infiltrating-patient-derived-breast-cancer-scaffolds/351464.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn Holloway","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the single-cell triomics approach measure in tumor cells?","Question",{"text":63,"@type":64},"It measures DNA, RNA, and proteins from the same single cell using a targeted sequencing approach, enabling integrated multi-layer biomarker analysis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the breast cancer cells modeled in the study?",{"text":68,"@type":64},"Cells were analyzed both in traditional monolayers and in patient-derived scaffolds designed to mimic in vivo growth conditions, including chemotherapy-treated and untreated settings.",{"name":70,"@type":61,"acceptedAnswer":71},"What effect did chemotherapy and scaffold microenvironments have on tumor cell heterogeneity?",{"text":72,"@type":64},"Chemotherapy caused changes in tumor cell subpopulations and biomarker expression. Additionally, scaffolds derived from different breast cancers produced distinct effects on heterogeneity and drug resistance due to tumor-specific microenvironments.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351464,1790153369,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","The American Journal of Pathology, Vol. 196, No. 4, April 2026  \nTUMORIGENESIS AND NEOPLASTIC PROGRESSION  \nSingle-Cell Triomics Analysis of Tumor Cells Infiltrating Patient-Derived Breast Cancer Scaffolds  \nStefan Filges, * Emma Jonasson, * Maria Del Carmen Leiva Arrabal, * Lisa Andersson, * Anna Gustafsson, * Dalia Dhingra,† Pedro Mendez,† Aik Ooi,† Adam Sciambi,† Göran Landberg, * David Ruff,† and Anders Ståhlberg*‡§¶  \nFrom the Sahlgrenska Center for Cancer Research,* Department of Laboratory Medicine, Institute of Biomedicine, Wallenberg Centre for Molecular and Translational Medicine,§ and Science for Life Laboratory,¶ Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden; Mission Bio, Inc.,† South San Francisco, California; and the Department of Clinical Genetics and Genomics,‡ Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.  \nAccepted for publication December 29, 2025.  \nAddress correspondence to Anders Ståhlberg, Ph.D., Sahlgrenska Center for Cancer Research, University of Gothenburg, Box 425, 405 30 Göteborg, Sweden.  \nE-mail: anders.stahlberg@gu. se.  \nCellular heterogeneity plays a critical role in tissues and diseases, including cancer. Single-cell technologies are required to provide detailed information about the phenotype and genotype of individual cells. Despite several approaches to analyzing different analytes at the single-cell level, it is challenging to assess DNA, RNA, and protein simultaneously. Here, a single-cell triomics method to assess DNA, RNA, and proteins from the same cell using a targeted sequencing approach is shown. Breast cancer cells cultured in monolayers and in patient-derived scaffolds that mimic in vivo—like growth conditions, both with and without chemotherapy treatment, were analyzed. Data showed that DNA, RNA, and protein biomarkers could be reliably analyzed, providing biological insights into breast cancer cell heterogeneity. In addition, chemotherapy treatment caused changes in subpopulations and expressions of biomarkers. Furthermore, cells growing in patient-derived scaffolds generated from various breast cancers affected cell heterogeneity and drug resistance differently as a result of the unique tumor-specific microenvironments. The data show that single-cell triomics provides new means to assess cancer cell heterogeneity at DNA, RNA, and protein levels. (Am J Pathol 2026, 196: 1016—1027; [https://doi.org/10.1016/j.ajpath.2025.12.013](https://doi.org/10.1016/j.ajpath.2025.12.013))  \nCancer is caused by mutations that modulate different signaling pathways and biological processes.1 Cancer cells display large heterogeneity both between and within tumors, where intratumor heterogeneity can occur at genetical, transcriptional, and translational levels.2 This variability results in tumor cell subpopulations with distinct molecular and cellular characteristics, including cancer stem cell (CSC)-like cells that constitute a small, slowly proliferating and tumor-sustaining proportion of the cancer. From these, highly proliferating expansion phase cells are generated that eventually may mature into more differentiated and senescent tumor cell types. CSCs are also associated with both drug and radiotherapy resistance.3,4 The mutational landscape and the ability of tumor cells to  \nacquire new mutations and cellular properties play key roles in the development of therapy resistance, determining patient outcome.5  \nTumor cells also reside in heterogenic microenvironments that are composed of multiple tumor cell types and stromal cells such as fibroblasts, endothelial cells, and  \nSupported by the Assar Gabrielssons Research Foundation; Stiftelsen Sigurd och Elsa Goljes Minne; Swedish Cancer Society grants 22-2080 (A.St.), 25-4425 (A.St.), and 22-2214 (G.L.); Swedish Research Council grants 2021-01008 (A.St.) and 2019-01273 (G.L.); Swedish governmental funding of clinical research (ALF) grants 1006009 (A.St.) and 965580 (G.L.); Sweden’s Innovat","cbCaihPgaMMGCxYd","https://ap.wps.com/l/cbCaihPgaMMGCxYd","pdf",4123879,12,"English","# Tumor heterogeneity and microenvironmental drivers\n## Single-cell technologies and multi-analyte profiling needs\n# Single-cell triomics method\n## Targeted sequencing for DNA, RNA, and proteins\n# Experimental setup\n## Monolayer vs patient-derived scaffolds\n## Chemotherapy and biomarker profiling\n# Findings and implications\n## Subpopulation shifts and drug resistance mechanisms","[{\"question\":\"What does the single-cell triomics approach measure in tumor cells?\",\"answer\":\"It measures DNA, RNA, and proteins from the same single cell using a targeted sequencing approach, enabling integrated multi-layer biomarker analysis.\"},{\"question\":\"How were the breast cancer cells modeled in the study?\",\"answer\":\"Cells were analyzed both in traditional monolayers and in patient-derived scaffolds designed to mimic in vivo growth conditions, including chemotherapy-treated and untreated settings.\"},{\"question\":\"What effect did chemotherapy and scaffold microenvironments have on tumor cell heterogeneity?\",\"answer\":\"Chemotherapy caused changes in tumor cell subpopulations and biomarker expression. Additionally, scaffolds derived from different breast cancers produced distinct effects on heterogeneity and drug resistance due to tumor-specific microenvironments.\"}]","Single-Cell Triomics Analysis of Tumor Cells Infiltrating Patient-Derived Breast Cancer Scaffolds | PDF",1790094299,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d21d3dfa2c90d028e74b1c8c1fd4c1e.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a39eb2b9b673e25148cfcd358b7d724.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d21c486cafaa4f4dffe463cdebbb03e.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ae5a6d772ba83a87a9933da51c0aacf.webp",980,1311]